We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+13.15%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$953M
AUM Growth
+$238M
Cap. Flow
+$172M
Cap. Flow %
18.06%
Top 10 Hldgs %
29.58%
Holding
2,093
New
545
Increased
515
Reduced
433
Closed
532

Sector Composition

Rank Sector Weight
1 Technology 11.14%
2 Healthcare 9.39%
3 Energy 7%
4 Industrials 6.24%
5 Real Estate 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SC
1526
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$2K ﹤0.01%
+200
New +$2.31K
ZIXI
1527
DELISTED
Zix Corporation
ZIXI
$2K ﹤0.01%
600
-4,200
-88% -$16.6K
PFNX
1528
DELISTED
Pfenex Inc.
PFNX
$2K ﹤0.01%
200
-10,300
-98% -$87.9K
PIR
1529
DELISTED
Pier 1 Imports, Inc.
PIR
$2K ﹤0.01%
20
-680
-97% -$64K
MCF
1530
DELISTED
Contango Oil & Gas Co.
MCF
$2K ﹤0.01%
200
-200
-50% -$2.06K
RTK
1531
DELISTED
Rentech, Inc.
RTK
$2K ﹤0.01%
600
-3,100
-84% -$9.41K
CPSS icon
1532
Consumer Portfolio Services
CPSS
$206M
$1K ﹤0.01%
+200
New +$811
ENPH icon
1533
Enphase Energy
ENPH
$5.53B
$1K ﹤0.01%
+1,200
New +$2.11K
NWG icon
1534
NatWest
NWG
$76.4B
$1K ﹤0.01%
186
-2,600
-93% -$13.9K
RH icon
1535
RH
RH
$3.71B
$1K ﹤0.01%
+28
New +$892
TROW icon
1536
T. Rowe Price
TROW
$24.3B
$1K ﹤0.01%
+20
New +$1.39K
GENE
1537
DELISTED
Genetic Technologies Ltd.
GENE
$1K ﹤0.01%
+15
New +$611
STML
1538
DELISTED
Stemline Therapeutics, Inc.
STML
$1K ﹤0.01%
+100
New +$813
AVEO
1539
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1K ﹤0.01%
100
-60
-38% -$565
CBK
1540
DELISTED
Christopher & Banks Corporation
CBK
$1K ﹤0.01%
800
-3,900
-83% -$7.05K
JNP
1541
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$1K ﹤0.01%
200
-1,500
-88% -$9.92K
JUNO
1542
DELISTED
Juno Therapeutics, Inc.
JUNO
$1K ﹤0.01%
20
-480
-96% -$14.9K
TPLM
1543
DELISTED
Triangle Petroleum Corporation
TPLM
$1K ﹤0.01%
2,900
-1,200
-29% -$300
A icon
1544
Agilent Technologies
A
$41.2B
-400
Closed -$18K
AAL icon
1545
American Airlines Group
AAL
$10.6B
-7,085
Closed -$201K
ABM icon
1546
ABM Industries
ABM
$2.84B
-1,425
Closed -$52K
ABUS icon
1547
Arbutus Biopharma
ABUS
$915M
-100
Closed
ACHC icon
1548
Acadia Healthcare
ACHC
$2.94B
-2,241
Closed -$124K
ACIW icon
1549
ACI Worldwide
ACIW
$5.42B
-3,100
Closed -$60K
ADUS icon
1550
Addus HomeCare
ADUS
$2.23B
-2,500
Closed -$44K

Similar funds

Prelude Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Prelude Capital Management held 2,093 positions worth $953M, up 33% from $715M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $172M of net new capital in Q3 2016, opening 545 new positions and adding to 515 existing holdings. Its largest new stake was The WhiteWave Foods Company: 210,073 shares worth $11.4M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $6.57M trimmed.

  • Prelude Capital Management's largest Q3 2016 buy was The WhiteWave Foods Company: 210,073 shares worth $11.4M.
  • Prelude Capital Management added most to AVG Technologies N.V. in Q3 2016, an estimated $7.01M increase.
  • Prelude Capital Management's biggest Q3 2016 reduction was Alphabet (Google) Class A, cutting an estimated $6.57M.
  • Prelude Capital Management fully exited DREAMWORKS ANIMATION SKG INC CL-A in Q3 2016, selling an estimated $9.69M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $953M portfolio in Q3 2016.
  • Prelude Capital Management opened 545 new positions and closed 532 in Q3 2016.
  • Prelude Capital Management's portfolio value rose 33% quarter-over-quarter to $953M.

Based on Prelude Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.